ADXSW
Advaxis, Inc.
Halal Rating :
Last Price
$0.00
Last updated:
Market Cap
-
7D Change
0.0%
1 Year Change
0.0%
Company Overview
Industries
Exchange
Next Earnings Date
Note: Advaxis, Inc. completed a merger with Ayala Pharmaceuticals in March 2023, and now operates under the name Ayala Pharmaceuticals, Inc. (AYLA).
Advaxis, Inc. was a clinical-stage biotechnology company focused on developing immunotherapy products to treat cancer. The company was engaged in the discovery, development, and commercialization of proprietary Listeria monocytogenes (Lm) based antigen delivery products.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| June 30, 2023 | $9000.0 | $8.49m | - | - | 0.00% | 0.00% |
Company Impact
Help us evaluate Advaxis, Inc.'s impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.